151 related articles for article (PubMed ID: 11071274)
21. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
Kalams SA; Goulder PJ; Shea AK; Jones NG; Trocha AK; Ogg GS; Walker BD
J Virol; 1999 Aug; 73(8):6721-8. PubMed ID: 10400770
[TBL] [Abstract][Full Text] [Related]
22. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
[TBL] [Abstract][Full Text] [Related]
23. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.
Spiegel HM; DeFalcon E; Ogg GS; Larsson M; Beadle TJ; Tao P; McMichael AJ; Bhardwaj N; O'Callaghan C; Cox WI; Krasinski K; Pollack H; Borkowsky W; Nixon DF
J Infect Dis; 1999 Aug; 180(2):359-68. PubMed ID: 10395850
[TBL] [Abstract][Full Text] [Related]
24. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
[TBL] [Abstract][Full Text] [Related]
25. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
Klein MR; van Baalen CA; Holwerda AM; Kerkhof Garde SR; Bende RJ; Keet IP; Eeftinck-Schattenkerk JK; Osterhaus AD; Schuitemaker H; Miedema F
J Exp Med; 1995 Apr; 181(4):1365-72. PubMed ID: 7699324
[TBL] [Abstract][Full Text] [Related]
27. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
28. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression.
Lubaki NM; Ray SC; Dhruva B; Quinn TC; Siliciano RF; Bollinger RC
J Infect Dis; 1997 Jun; 175(6):1360-7. PubMed ID: 9180175
[TBL] [Abstract][Full Text] [Related]
30. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Malhotra U; Kaushik S; Dar L; Mojumdar K; Chauhan NK; Sreenivas V
Med Microbiol Immunol; 2009 Feb; 198(1):47-56. PubMed ID: 18985383
[TBL] [Abstract][Full Text] [Related]
32. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
33. Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.
Greenough TC; Brettler DB; Kirchhoff F; Alexander L; Desrosiers RC; O'Brien SJ; Somasundaran M; Luzuriaga K; Sullivan JL
J Infect Dis; 1999 Dec; 180(6):1790-802. PubMed ID: 10558933
[TBL] [Abstract][Full Text] [Related]
34. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
[TBL] [Abstract][Full Text] [Related]
35. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.
Kalams SA; Buchbinder SP; Rosenberg ES; Billingsley JM; Colbert DS; Jones NG; Shea AK; Trocha AK; Walker BD
J Virol; 1999 Aug; 73(8):6715-20. PubMed ID: 10400769
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.
Greenough TC; Brettler DB; Somasundaran M; Panicali DL; Sullivan JL
J Infect Dis; 1997 Jul; 176(1):118-25. PubMed ID: 9207357
[TBL] [Abstract][Full Text] [Related]
37. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
38. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.
McGuire TC; Tumas DB; Byrne KM; Hines MT; Leib SR; Brassfield AL; O'Rourke KI; Perryman LE
J Virol; 1994 Mar; 68(3):1459-67. PubMed ID: 8107209
[TBL] [Abstract][Full Text] [Related]
39. In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy.
Buseyne F; Le Chenadec J; Burgard M; Bellal N; Mayaux MJ; Rouzioux C; Rivière Y; Blanche S
AIDS Res Hum Retroviruses; 2005 Aug; 21(8):719-27. PubMed ID: 16131312
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
